Laboratory Medicine and Quality Assurance

Table. 1.

Number of participants and NGS challenges during 2017–2019

Round Sample Participants Target Type of variant

No variant Single nucleotide variant Indel
2017-1 NGS(G)-17-01 5 35 11 23 1
2017-2 NGS(G)-17-02 6 49 16 29 4
2018-1 NGS(G)-18-01 18 50 13 33 4
NGS(G)-18-02 15 50 15 33 2
2018-2 NGS(G)-18-03 17 49 13 34 2
NGS(G)-18-04 17 52 16 34 2
2019-1 NGS(G)-19-01 19 50 15 31 4
NGS(G)-19-02 22 50 16 32 2
2019-2 NGS(G)-19-03 19 50 13 35 2
NGS(G)-19-04 22 50 20 30 0
NGS(G)-19-05 13 50 16 23 11
Mean 15.7 48.6 14.9 (30.7) 30.6 (63.0) 3.1 (6.4)

Values are presented as number or number (%).

Abbreviation: NGS, next-generation sequencing.

Lab Med Qual Assur 2020;42:48~53 https://doi.org/10.15263/jlmqa.2020.42.1.48
© Lab Med Qual Assur